There is a growing need to develop lead-free shielding materials that are safe, low weight, durable, environmentally friendly, chemically and mechanically stable and customizable for specific applications. Fused deposition modeling (FDM), an additive manufacturing technique based on the extrusion of a thermoplastic filament into a 3D printed object one layer at a time, could be employed well in applications involving ionizing radiation due to its relatively low cost, design flexibility and high manufacturing precision. This study aimed at developing 3D printing composites that contain Titanium dioxide as a filler agent for shielding in a medical radiation environment. First, the effect of low-dose ionizing radiation (up to 15 Gy) on the mechanical properties of common 3D printing polymers, ABS, ULTRAT, PLA, NYLON, ASA and PETG, was investigated. Since ABS experienced the lowest variation in its ultimate tensile strength (±5%) and Young’s modulus (−5%/+11%), it was chosen as a matrix for a new extruded 3D filament containing TiO2 at 1 wt.%, 3 wt.%, and 5 wt.%. With the incorporation of TiO2 at different filler contents, the UTS of the ABS composites varied between 24.1 MPa and 28.4 MPa, with the highest value recorded for 3 wt.% TiO2. Young’s modulus values were dependent on both the TiO2 concentration and on the irradiation dose. In addition, the ABS/TiO2 composites with a higher filler content (3 wt.% and 5 wt.%) maintained their attenuation ability even after exposure to a radiation dose of 100 Gy as opposed to pure ABS, which exhibited a ~2.5% reduction in its mass attenuation coefficient after exposure to the same dose of radiation. The pilot investigation performed demonstrated that the newly developed ABS/TiO2 composite containing 5 wt.% of filler can be successfully employed to shield electronic devices operating in a radiotherapy room.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.